U.S. Patent Application Publication
On October 3, 2023, the United States Patent and Trademark Office published U.S. Patent Application 2023/0310474 titled Coronavirus Treatment Composition and Method that names Dr. Xue-Long Sun, a professor in the Department of Chemistry and member of CSU’s Center for Gene Regulation in Health and Disease (GRHD).
The invention includes a new pathway of coronavirus replication, a new mechanism to regulate coronavirus replication, a new drug target to regulate coronavirus replication, and new therapeutic approach for coronavirus infection, especially for COVID-9 caused by SARS-CoV-2 virus. |
|
Patent Review Committee Decisions
The CSU Patent Review Committee approved two invention disclosures for patent protection. The disclosures were provided by Dr. Kailash Gulshan, an assistant professor in the Department of Biology, Geology, and Environmental Science (BGES) and a member of GRHD.
The first invention disclosure, titled Novel role of PIP2 in regulating expression of cholesterol efflux pump ABCA1, relates to a novel approach of preventing atherosclerosis. Dr. Gulshan’s second invention is titled TATP8b1 as a first known PIP2 flippase from any system and relates to a novel method for treatment of fibrosis and the prevention of adolescent liver disease. |